IHC results demonstrated that EBP50 was expressed in the majority of the pancreatic cancer tissues (75/120, 62.5%); 38 tissue samples (31.67%) were scored as 1+, 22 (18.33%) cases were scored as 2+ and 15 (12.5%) cases were scored as 3+ (Fig. 1A). The gene discussed is NHERF1; the disease is pancreatic neoplasm.